For each of the five discovery datasets, GJB2 expression was markedly elevated while ERO1LB expression significantly reduced in pancreatic adenocarcinoma samples than in control samples (Figure 3A–3B). The gene discussed is GJB2; the disease is pancreatic adenocarcinoma.